SCHEMBL5154634

SCHEMBL5154634

COCC(=O)Nc1nc2ccc(OS(=O)(=O)c3ccccc3)cc2s1

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 6/20 0.66
RAB9A P51151 6/20 0.66
SMN1; SMN2 Q16637 6/20 0.66
TP53 P04637 4/20 0.66
POLB P06746 2/20 0.66
ALDH1A1 P00352 5/20 0.61
MAPT P10636 5/20 0.61
MAPK1 P28482 2/20 0.61
GAA P10253 1/20 0.61
MEN1 O00255 5/20 0.58
KMT2A Q03164 5/20 0.58
KDM4E B2RXH2 2/20 0.58
RXFP1 Q9HBX9 2/20 0.57
CASP2 P42575 1/20 0.54
HTT P42858 2/20 0.54
SCD O00767 1/20 0.53
TSHR P16473 1/20 0.53
CSNK1D P48730 2/20 0.53
LMNA P02545 2/20 0.53
NFKB1 P19838 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4405589 0.90 NPC1 (0.63) NPC1RAB9ASMN1; SMN2TP53POLB
SCHEMBL5158057 0.86 DYRK1A (0.65) NPC1RAB9ASMN1; SMN2TP53POLB
SCHEMBL4399574 0.83 SMN1; SMN2 (0.55) NPC1RAB9ASMN1; SMN2TP53POLB
SCHEMBL4396844 0.83 SMN1; SMN2 (0.55) NPC1RAB9ASMN1; SMN2TP53POLB
Hydrochloric Acid SCHEMBL4398837 0.82 SMN1; SMN2 (0.54) NPC1RAB9ASMN1; SMN2TP53POLB
SCHEMBL4396993 0.80 ALDH1A1 (0.55) NPC1RAB9ASMN1; SMN2TP53POLB
SCHEMBL5186173 0.80 MAPT (0.52) NPC1RAB9ASMN1; SMN2POLBALDH1A1
SCHEMBL9332424 0.79 SMN1; SMN2 (1.00) NPC1RAB9ASMN1; SMN2TP53POLB
SCHEMBL4399543 0.78 RAB9A (0.66) NPC1RAB9ASMN1; SMN2TP53POLB
SCHEMBL5154663 0.78 NPC1 (0.51) NPC1RAB9ASMN1; SMN2ALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1745044-A2 BENZOTHIAZOLE DERIVATIVES HAVING CDK MODULATING ACTIVITY AND USE THEREOF AS ANTICANCER AGENTS Aventis Pharma S.A. (FR) 2007-01-24 EP disclosed
WO-2005097787-A2 NOVEL BENZOTHIAZOLES AND THE USE THEREOF AS MEDICAMENTS AVENTIS PHARMA S.A. (FR) 2005-10-20 WO disclosed